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and Abbott assays, following manufacturers' protocol. VL results obtained from FTA 1 1 6 cards specimens were then compared with that of plasma specimens (gold 1 1 7 standard). The statistical analyzes were performed using RStudio (Version 0.99.903).
Sensitivity, specificity predictive positive value and predictive negative value were 1 2 1 estimated to determine the performances of FTA cards for quantification of HIV-1 VL 1 2 2 at a viral load threshold of 1000 copies/ml, a decision point for therapeutic efficacy. test. All HIV-1 VL values were log10 transformed prior Bland-Altman and correlation analysis. The significance level was set at a p-value of 0.05. An informed consent form was presented to each patient prior to blood collection and 1 3 1 patients who gave verbal consent were enrolled. Additionally, in order to guarantee 1 3 2 confidentiality, random anonymous identification numbers were assigned to each and plasma specimens values (Figure 2A) . Bland-Altman analysis showed bias of -1 8 5 0.3 and 95% limits of agreement of -2.6 to 1.8 log10; total number of cases within 1 8 6 agreement limits in this study was 97/99 (97.9%) ( Figure 3A) . The correlation between VL values obtained from FTA cards and plasma specimens 1 9 0 tested was strong (R 2 = 0.764; p-value < 2.2e-16) ( Figure 2B ). Bland-Altman analysis 1 9 1 showed bias of -0.1 and 95% limits of agreement of -2.3 to 2.1 log10; total number of 1 9 2 cases within agreement limits in this study was 96/99 (96.9%) ( Figure 3B ). Faso, another type of paper (FTA cards) is now also routinely used for sample 1 9 8 collection during malaria vigilance programs and antimalarial drug trials. In this study, 1 9 9 FTA cards was evaluated as an alternative sample collection method to plasma for 2 0 0 HIV-1 RNA quantitation using commercial Roche and Abbott assays. To the best of 2 0 1 our knowledge, this was the first study to evaluate and compare the use of FTA cards 2 0 2 filter paper (for DBS) to plasma specimens for VL testing using both Roche and 2 0 3 Abbott assays. In our study, no statistical differences (p-value > 0.05) were observed between the 2 0 5 mean VL obtained from FTA cards and plasma specimens using Roche and Abbott 2 0 6 assay. These findings are similar to those of previous reports obtained using Hematocrit has been suggested to recalculate DBS VL to plasma VL copies/mL by with the Roche and Abbott assays. could be more relevant to specimens with low or undetectable levels viremia than to 2 3 2 specimens containing higher levels of extracellular HIV-1 RNA.
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At the clinical threshold of 1000 copies/mL, sensibility of FTA cards in this study was 2 3 4 seen at 78.6% with Roche, which was slightly less than that observed with Abbott Table 3 : Sensitivity, specificity, positive predictive value, and negative predictive using Abbott assay.
